Amphastar Pharmaceuticals (AMPH) Operating Income Growth (5y) (2018 - 2026)
Amphastar Pharmaceuticals (AMPH) Operating Income Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.05 Bn | 43.08 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.39 Bn | 39.74 Bn | 2.15 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.78 Bn | 22.99 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.92 Bn | 11.39 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 9.99 Bn | - |
| 10 | Amphastar Pharmaceuticals | 933.33 Mn | 643.20 Mn | 93.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 30.34% |
| Mar 31, 2026 | 5.75% |
| Dec 31, 2025 | 65.37% |
| Sep 30, 2025 | 48.41% |
| Jun 30, 2025 | 75.05% |
| Mar 31, 2025 | 37.89% |
| Dec 31, 2024 | 184.69% |
| Sep 30, 2024 | 88.39% |
| Jun 30, 2024 | 124.28% |
| Mar 31, 2024 | 76.51% |
| Dec 31, 2023 | 103.55% |
| Sep 30, 2023 | 95.42% |
| Jun 30, 2023 | 70.82% |
| Mar 31, 2023 | 40.21% |
| Dec 31, 2022 | 88.29% |
| Sep 30, 2022 | 58.15% |
| Jun 30, 2022 | 62.59% |
| Mar 31, 2022 | 72.77% |
| Dec 31, 2021 | 47.68% |
| Sep 30, 2021 | 33.70% |